Chico CA, Bertoli GL, Estévez TM, Kokuina E, Casas FN, Sánchez BY

Language: Spanish
References: 28
Page: 1-13
PDF size: 369.95 Kb.

ABSTRACT

Introduction: Rheumatoid arthritis within its expression as a systemic inflammatory disease presents extra-articular manifestations.
Objectives: To determine the frequency of extra-articular manifestations in patients with rheumatoid arthritis, to identify the most frequent and their association with antibodies against citrullinated cyclic peptides.
Methods: A descriptive and cross-sectional study was carried out in 101 patients with a diagnosis of rheumatoid arthritis, assisted in the protocolized consultation of Rheumatology service at Hermanos Ameijeiras Clinical Surgical Hospital, from August to December 2019. Sociodemographic characteristics were identified, such as age, sex, time of evolution of rheumatoid arthritis, smoking habits. The presence of extra-articular manifestations was searched for by questioning, physical examination and with the help of complementary tests, and the titers of antibodies against citrullinated cyclic peptides were determined in the plasma of the patients.
Results: Extra-articular manifestations were present in 38 patients, 37.6% of the cases, the most frequent were subcutaneous nodules in 37 patients, and anemia in 35, which constituted 36.6% and 34.7% of the cases, respectively. Seventy eight patients were positive for citrullinated cyclic antipeptides, 77.2% of the sample, there was no association between the presence of citrullinated cyclic antipeptides and the activity of the disease. There was no significant association between the presence of these antibodies and the presence of extra-articular manifestations p <0.0001, the association between the levels of citrullinated cyclic antipeptides and the number of extra-articular manifestations in a patient was significant p=0.0018.
Conclusions: The existing joint manifestations in the studied patients were significantly associated with the presence of citrullinated cyclic antipeptides.

REFERENCES

1. Aletaha D, Neogi T, Si lman AJ, Funovits J, Felson DT, Bingham CO,et al. Rheumatoid arthritis classi fication criteria: an AmericanCol lege of Rheumatology/European league against rheumatismcol laborative initiative. Arthritis Rheum. 2010;62:2569-81.

2. Carbonel l J. Manifestaciones extrarticulares de la artritisreumatoide. Barcelona: Espańa. 1990. Pp: 43-59.

3. Ahlmen M, Svensson B, Albertsson K, Forslind K, Hasfstro.Influence of gender on assessments of disease activity and functionin early rheumatoid arthritis in relation to radiographic jointdamage. Ann Rheum Dis. 2010[acceso: 20/08/2020];69(1) :230-3.Disponible en: https://ard.bmj.com/content/69/01/230. long

4. Areskoug Josefsson K, Oberg U. A literature review of the sexual health ofwomen with rheumatoid arthritis. Musculoskeletal Care. 2019[acceso:20/08/2020];7(4):219-26. Disponible en:https://onlinelibrary.wiley.com/doi/epdf/10.1002/msc.152

5. Reyes Llerena GA, Guibert Toledano M, Penedo Coel lo A, PérezRodríguez A, Baez Duenas RM, Charnicharo Vidal R, et al. Communitybasedstudy to estimate prevalence and burden of i l lness ofrheumatic diseases in Cuba: a COPCORD study. J Clin Rheumatol.2009;15(2):51-5. DOI:https://doi.org/10.1097/RHU.0b013e31819b61cb

6. Hochberg MC. Extrarticular manifestations in rheumatoid arthritis.Rheumatology. Sixth edition. Phi ladelphia: Elsevier Ltd. 2015.pp:300-40. Disponible en:https://www.elsevier.com/books/rheumatology-2-volumeset/hochberg/978-0-323-09138-1

7. Myasoedova E, Crowson CS, Turesson C. Incidence and mortality ofextra-articular rheumatoid arthrit is in Olmsted County, Minnesota,1995-2007: a population based study. J Rheumatol. 2011[acceso:20/08/2020];38:983-9. Disponible enhttps://www.ncbi.nlm.nih.gov/pmc/art icles/PMC3193155/pdf/nihms288339.pdf

8. Turesson C, McClel land RL, Christianson T, Matteson E. Clusteringof extra-articular manifestations in patients with rheumatoidarthritis. J Rheumatol. 2016[acceso: 20/08/2020];43:1 -4. Disponibleen: https://www.jrheum.org/content/35/1/179. long

9. Arnett FC, Edworthy SM, Bloch DA, Mchane DJ, Fries JF, CoopersNS, et al. The American Rheumatism Association 1987 revised criteriafor the classification of rheumatoid arthritis. Arthritis Rheum.1988;31:315-24.

10. Van Zeben D, Hazes JMW, Zwinderman AH, Cats A, Van der VoortEAM, Breedveld FC, et al. Clinical significance of rheumatoid factorsin early rheumatoid arthritis: a results of a fol low- up study. AnnRheum Dis. 1992;51:1029-35.

11. Van Gaalen FA, Linn-Rasker SP, Van Venrooij WJ, de Jong BA,Breedveld FC, Verweij CL, et al. Autoantibodies to cycliccitrul linated peptides predict progression to rheumatoid arthritis inpatients with undi ferentiated arthrit is: a prospective cohort study.Arthritis Rheum. 2016[acceso: 20/08/2020];50:709-15. Disponible en:https://onlinelibrary.wi ley.com/doi/epdf/10.1002/art.20044

12. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, StenlundH, et al. Antibodies against cyclic Citrullinated peptide and IgA rheumatoid factorpredict the development of rheumatoid arthritis. Arthritis Rheum. 2016[acceso:20/08/2020];48:2741-9. Disponible en:https://onlinelibrary.wiley.com/doi/10.1002/art.11223

13. Brzustewicz E, Henc I, Daca A, Szarecka M, Sochocka -Bykowska M,Witkowski J, et al. Autoantibodies, C-reactive protein, erythrocytesedimentation rate and serumcytokine profi ling in monitoring of earlytreatment. Cent Eur J Immunol. 2017[acceso: 20/08/2020];42:259 -68.Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708207/

14. Coutant F. Pathogenic effects of anti -citrul linated proteinantibodies in rheumatoid arthritis -role for glycosylation. J BoneSpine. 2019;86:562-7. DOI: https://doi.org/10.1016/j.jbspin.2019.01.005

15. Trier NH, Houen G. Epitope Specificity of Anti -Citrul linatedProtein Antibodies. Antibodies(Basel). 2017;6(1):5. DOI:https://doi.org/10.3390/antib6010005:157-9

16. Van der Heijde DM, Van´thof MA, Van riel PL. Judging diseaseactivity in clinical practice in rheumatoid arthritis: first step indevelopment of a disease activity score. Ann Rheum Dis.1990;11:1812-22. DOI: https://doi.org/10.1136/ard.49.11.916

17. Prevoo ML, Van´thof MA, Kupper HH. Modi fied disease activityscores that include twenty-eight-joints counts. Development andvalidation in a prospective longitudinal study of patients withrheumatoid arthritis. Arthritis Rheum. 1995;38:44-8.

18. Alpízar-Rodríguez D, Muel ler D, Mol ler B, Dudler J, Ciurea A,Zufferey P, et al. Female hormonal factors and the development ofanti-citrullinated protein antibodies in women at risk of rheumatoidarthritis. Rheumatology (Oxford). 2017[acceso:16/09/2020];56(9):1579-85. DOI:https://doi.org/10.1093/rheumatology/kex239

19. Sparks JAC, Chang SC, Liao KP. Incident rheumatoid arthritis andrisk of mortality among women fol lowed prospectively from 1976 to 2010 in the Nur se s ’ Health Study. Arthritis Rheumatol. 2016; 6 6: 3 59 -70. DOI: https://doi.org/10.1002/acr.22752

20. Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D,Burmester G, et al. Expert Committee: Treating rheumatoid arthritisto target: recommendations of an international task force. AnnRheum Dis. 2016;69:631-7. DOI:https://doi.org/10.1136/ard.2009.123919

21. Sockalingam S, Khuan CS, Sthaneshwar P. Prevalence of anti-cycliccitrullinated peptide antibodies in Malaysian rheumatoid arthritis patients and itscorrelation with disease activity. Int J Rheum Dis. 2018;12:211-5. DOI:https://doi.org/10.1111/j.1756-185X.2009.01412

22. Wahab A, Mohammad M, Rahman MM. Anti -cyclic citrul linatedpeptide antibody is a good indicator for the diagnosis of rheumatoidarthritis. Pak J MedSci. 2013;29:773-805.

23. Watad A, Amital H. ACPAs Are Much More Than Diagnostic.Autoantibodies. Rambam Maimonides Med J. 2016;7(4):10 260-7. DOI.https://doi.org/10.5041/RMMJ.10255

24. Hedstrom AK, Stawiarz L, Klareskog L, Alfreddsson L. Smoking andsusceptibi lity to rheumatoid arthritis in a Swedish population -basedcase-control study. European Journal of Epidemiology. 2018;33:415 -23. DOI: https://doi.org/10.1007/s10654-018-0360-5

25. Richman NC, Yazdany J, Graf J. Extrarticular manifestations ofrheumatoid arthritis in a multiethnic cohort of predominantly Hispanic and Asian patients. Medicine (Baltimore). 2013;92:92-7.

26. Agrawal S, Misra R, Aggarwal A. Anemia in rheumatoid arthritis:high prevalence of iron-deficiency anemia in Indian patients.Rheumatol Int. 2006;26:1091-5.

27. Vela P. Extra-articular manifestations of rheumatoid arthritis,now. EMJ Rheumatol. 2014;1:103-12.

28. Korkmaz C, Us T, Kasi foglu T. Anti -cyclic citrul linated peptide(CCP) antibodies in patients with long-standing rheumatoid arthritisand their relationship with extra-articular manifestations. ClinBiochem. 2016;39:9615DOI: https://doi.org/10.1016/j.clinbiochem.2006.06.004